Ladiratuzumab vedotin, CAS [[1629760-29-7]]

Produktübersicht

• Artikelname: Ladiratuzumab vedotin, CAS [[1629760-29-7]]
• Artikelnummer: MCE-HY-P99683
• Hersteller Artikelnummer: HY-P99683
• Alternativnummer: MCE-HY-P99683-10MG,MCE-HY-P99683-1MG,MCE-HY-P99683-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: SGN-LIV1A

Produktbeschreibung

Ladiratuzumab vedotin (SGN-LIV1A) is a LIV-1 targeting antibody drug conjugate (ADC) (IC50: 5.6 nM for LIV-1). Ladiratuzumab vedotin consists of humanized IgG1 monoclonal antibody, MMAE and a protease-cleavable linker. Ladiratuzumab vedotin can drive immunogenic cell death (ICD) to elicit an immune response. Ladiratuzumab vedotin can be used for research of breast cancer[1][2][3][4].

Produkteigenschaften

• Reinheit: 99.80
• CAS Nummer: [1629760-29-7]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)

Anwendungsbeschreibung

• Anwendungsbeschreibung: ADC Related